摘要
目的解析度洛西汀在中国的专利概况,为国内制药企业制定研发战略提供参考。方法运用定性和定量分析方法,对1987至2012年间度洛西汀在中国的专利信息进行统计处理,得出结论。结果与结论度洛西汀虽无化合物专利,但具有药品行政保护,并具有一系列剂型、晶型、工艺和组方专利,保护期限各不相同,我国仿制企业需认真研究,以制定有效的研发策略。
OBJECTIVE To find out the patent situation of duloxetine and provide references for domestic pharmaceutical companies to establish appropriate R＆D strategies. METHODS The patent situation of duloxetine in China, such as the numbers of applications,dis- tribution, the applicants, legal status, patent contents etc. during the year of 1987--2012 are statistically analyzed by methods of quantitative and qualitative analysis. RESULTS AND CONCLUSION Duloxetine has administrative protection but no compound patent in China. M- though the number of valid patents is not very high, but we still need to pay attention to patents of crystal and method to avoid infringement.
出处
《中国药学杂志》
CAS
CSCD
北大核心
2014年第19期1770-1772,共3页
Chinese Pharmaceutical Journal
关键词
抗抑郁药
度洛西汀
专利分析
antidepressant drug
duloxetine
patent analysis
